✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Oxygenta Pharmaceutical Ltd.

OXYGENTAPH

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹234 Cr.
P/E
0.00

Oxygenta Pharmaceutical Ltd.

  • Oxygenta Pharma
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

FAQs on Oxygenta Pharmaceutical Ltd. Shareprice

Oxygenta Pharma has given better returns compared to its competitors.
Oxygenta Pharma has grown at ~26.04% over the last 10yrs while peers have grown at a median rate of 16.0%

There is insufficient historical data to gauge this.
Latest PE of Oxygenta Pharma is 0

View FAQ's On Business

Growth Table

  • Oxygenta Pharmaceutical Ltd.
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

Balance Sheet

  • Oxygenta Pharmaceutical Ltd.
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Oxygenta Pharmaceutical Ltd.
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

Cash Flow

  • Oxygenta Pharmaceutical Ltd.
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Oxygenta Pharmaceutical Ltd.
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

Quarterly Results

  • Oxygenta Pharmaceutical Ltd.
  • Ambalal Sarabhai Ent
  • Aarey Drugs & Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Oxygenta Pharmaceutical Ltd. Financials

Oxygenta Pharma balance sheet is weak and might have solvency issues

Yes, The net debt of Oxygenta Pharma is increasing.
Latest net debt of Oxygenta Pharma is ₹61.99 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹57.03 Crs.

No, profit is decreasing.
The profit of Oxygenta Pharma is -₹15.04 Crs for TTM, -₹9.68 Crs for Mar 2025 and -₹3.48 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Oxygenta Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech